Net profit of Indo US Bio-Tech declined 40.59% to Rs 3.00 crore in the quarter ended December 2025 as against Rs 5.05 crore during the previous quarter ended December 2024. Sales declined 3.23% to Rs 22.80 crore in the quarter ended December 2025 as against Rs 23.56 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 22.80 | 23.56 | -3 |
| OPM % | 18.20 | 23.47 | - |
| PBDT | 3.39 | 5.17 | -34 |
| PBT | 3.17 | 5.01 | -37 |
| NP | 3.00 | 5.05 | -41 |